119 related articles for article (PubMed ID: 27589390)
1. Different Biological Action of Oleic Acid in ALDHhigh and ALDHlow Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer.
Kim HS; Jung M; Choi SK; Moon WK; Kim SJ
PLoS One; 2016; 11(9):e0160835. PubMed ID: 27589390
[TBL] [Abstract][Full Text] [Related]
2. IL-6-mediated cross-talk between human preadipocytes and ductal carcinoma in situ in breast cancer progression.
Kim HS; Jung M; Choi SK; Woo J; Piao YJ; Hwang EH; Kim H; Kim SJ; Moon WK
J Exp Clin Cancer Res; 2018 Aug; 37(1):200. PubMed ID: 30134951
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
4. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
Yang M; Xu SP; Ao QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS).
He F; Springer NL; Whitman MA; Pathi SP; Lee Y; Mohanan S; Marcott S; Chiou AE; Blank BS; Iyengar N; Morris PG; Jochelson M; Hudis CA; Shah P; Kunitake JAMR; Estroff LA; Lammerding J; Fischbach C
Biomaterials; 2019 Dec; 224():119489. PubMed ID: 31546097
[TBL] [Abstract][Full Text] [Related]
6. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
Scribner KC; Behbod F; Porter WW
Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
[TBL] [Abstract][Full Text] [Related]
7. Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS).
Farnie G; Johnson RL; Williams KE; Clarke RB; Bundred NJ
Cell Cycle; 2014; 13(3):418-25. PubMed ID: 24247151
[TBL] [Abstract][Full Text] [Related]
8. Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro.
Nemec MJ; Kim H; Marciante AB; Barnes RC; Talcott ST; Mertens-Talcott SU
Food Funct; 2016 Sep; 7(9):3825-33. PubMed ID: 27491891
[TBL] [Abstract][Full Text] [Related]
9. Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer.
Pandey PR; Xing F; Sharma S; Watabe M; Pai SK; Iiizumi-Gairani M; Fukuda K; Hirota S; Mo YY; Watabe K
Oncogene; 2013 Oct; 32(42):5111-22. PubMed ID: 23208501
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
Farnie G; Willan PM; Clarke RB; Bundred NJ
PLoS One; 2013; 8(2):e56840. PubMed ID: 23457626
[TBL] [Abstract][Full Text] [Related]
11. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
[TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular characterization of two patient-derived ductal carcinoma in situ (DCIS) cell lines, ETCC-006 and ETCC-010.
Samson J; Derlipanska M; Zaheed O; Dean K
BMC Cancer; 2021 Jul; 21(1):790. PubMed ID: 34238275
[TBL] [Abstract][Full Text] [Related]
13. Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Shekhar MP; Tait L; Pauley RJ; Wu GS; Santner SJ; Nangia-Makker P; Shekhar V; Nassar H; Visscher DW; Heppner GH; Miller FR
Cancer Biol Ther; 2008 Nov; 7(11):1774-82. PubMed ID: 18787417
[TBL] [Abstract][Full Text] [Related]
14. Polyphenolics from mango (Mangifera indica L.) suppress breast cancer ductal carcinoma in situ proliferation through activation of AMPK pathway and suppression of mTOR in athymic nude mice.
Nemec MJ; Kim H; Marciante AB; Barnes RC; Hendrick ED; Bisson WH; Talcott ST; Mertens-Talcott SU
J Nutr Biochem; 2017 Mar; 41():12-19. PubMed ID: 27951515
[TBL] [Abstract][Full Text] [Related]
15. An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ.
Behbod F; Kittrell FS; LaMarca H; Edwards D; Kerbawy S; Heestand JC; Young E; Mukhopadhyay P; Yeh HW; Allred DC; Hu M; Polyak K; Rosen JM; Medina D
Breast Cancer Res; 2009; 11(5):R66. PubMed ID: 19735549
[TBL] [Abstract][Full Text] [Related]
16. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
Tait LR; Pauley RJ; Santner SJ; Heppner GH; Heng HH; Rak JW; Miller FR
Int J Cancer; 2007 May; 120(10):2127-34. PubMed ID: 17266026
[TBL] [Abstract][Full Text] [Related]
17. Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer.
Wang S; Li W; Liu N; Zhang F; Liu H; Liu F; Liu J; Zhang T; Niu Y
J Cell Biochem; 2012 Jun; 113(6):1904-14. PubMed ID: 22234886
[TBL] [Abstract][Full Text] [Related]
18. Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway.
Navarro-Tito N; Soto-Guzman A; Castro-Sanchez L; Martinez-Orozco R; Salazar EP
Int J Biochem Cell Biol; 2010 Feb; 42(2):306-17. PubMed ID: 19931412
[TBL] [Abstract][Full Text] [Related]
19. Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.
Barnes NL; Khavari S; Boland GP; Cramer A; Knox WF; Bundred NJ
Clin Cancer Res; 2005 Mar; 11(6):2163-8. PubMed ID: 15788662
[TBL] [Abstract][Full Text] [Related]
20. Is there 'progression through grade' in ductal invasive breast cancer?
Schymik B; Buerger H; Krämer A; Voss U; van der Groep P; Meinerz W; van Diest PJ; Korsching E
Breast Cancer Res Treat; 2012 Oct; 135(3):693-703. PubMed ID: 22886478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
